Key result
Concomitant CAD in AF is linked to ~82% greater risk of major cardiovascular events.
Why the study?
Patients with AF often have concomitant CAD, but there were little data regarding their clinical characteristics and outcomes in daily clinical practice in Japan.
Does concomitant coronary artery disease increase the risk of cardiovascular events in patients with atrial fibrillation?
Cohort (n=4,464)
Yes
Does concomitant coronary artery disease increase the risk of cardiovascular events in patients with atrial fibrillation?
Hazard Ratio: 1.82 (95% CI 1.53–2.18)
Absolute Event Rate: 5.1% vs 2.8%
p-value: p=<0.01
In Japanese patients with atrial fibrillation, concomitant coronary artery disease is associated with a higher incidence of cardiac events but does not independently increase the risk of stroke or systemic embolism.
Concomitant CAD signals higher cardiac event risk in AF patients; leaves open whether it independently modifies stroke/SE risk beyond comorbidities.
BACKGROUND: Atrial fibrillation (AF) patients often have concomitant coronary artery disease (CAD); however, there are little data on clinical characteristics and outcomes of such patients in daily clinical practice in Japan. METHODS AND RESULTS: The Fushimi AF Registry is a community-based prospective survey of AF patients in Fushimi-ku, Kyoto, Japan. Follow-up data were available for 4,464 patients, and the median follow up was 5.1 (interquartile range: 2.3-8.0) years. History of CAD was present in 647 patients (14%); of those patients, 267 (41%) had history of myocardial infarction (MI). Patients with CAD were older and had more comorbidities than those without CAD. The crude incidences (% per patient-year) of cardiovascular events were significantly higher in patients with CAD than those without CAD (cardiac death: 1.8 vs. 0.7, stroke or systemic embolism [SE]: 2.9 vs. 2.1, MI: 0.6 vs. 0.1, composite of those events: 5.1 vs. 2.8, respectively, all log-rank P<0.01). After multivariate adjustment, concomitant CAD was associated with incidence of cardiac events, and history of MI was associated with incidence of MI; however, neither history of CAD nor MI was associated with the incidence of stroke/SE. CONCLUSIONS: In Japanese AF patients, concomitant CAD was associated with higher prevalences of major co-morbidities and higher incidences of cardiovascular events; however, history of CAD was not associated with the incidence of stroke/SE.
No takes yet. Share an insight, caveat, or question.
Masunaga et al. (2022) conducted a cohort in Atrial fibrillation (n=4,464). Concomitant coronary artery disease vs. No coronary artery disease was evaluated on Composite of cardiac death, stroke/systemic embolism (SE) or MI (HR 1.82, 95% CI 1.53-2.18, p=<0.01). Concomitant coronary artery disease in patients with atrial fibrillation was associated with a significantly higher incidence of the composite of cardiac death, stroke/systemic embolism, or myocardial infarction (HR 1.82) compared to those without CAD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: